ArticleACS applied bio materials2026
Polycaprolactone/Polyethylene Glycol/Hydroxypropylmethylcellulose Blends: Tailoring Thermomechanical and Rheological Properties for Injection-Molded Capsules for Colon-Targeted Delivery Applications.
Article in ACS applied bio materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colon-targeted delivery systems offer a promising approach for local drug administration. In this study, we developed a customized polymeric blend for this purpose, combining polyethylene glycol (PEG), polycaprolactone (PCL), and hydroxypropyl methylcellulose (HPMC). Although PEG and PCL have been extensively studied, the inclusion of HPMC in such blends remains underexplored; however, its use in this context shows significant potential due to its pH sensitivity. To achieve this, various formulations were tested to optimize the thermomechanical and release characteristics of capsules produced through injection molding. Three blends containing 22, 24, and 34 wt% HPMC were processed and analyzed using rheological methods, ATR-FTIR, TGA, DSC, SEM, and in vitro release tests with methylene blue as a model compound. Simulated pH-release tests (pH 2.5, 5, and 6.8) showed minimal release in gastric and intestinal environments, with controlled and sustained release under colonic pH conditions. It was also observed that the initial HPMC content affects the release rate of the model compound. Specifically, when the blend contains 34% HPMC, approximately 38% of the compound is released within 12 h and 73% within 24 h. These results highlight the potential of pH-sensitive polymer blends as effective platforms for colon-targeted drug delivery. A model illustrating how the release rate depends on pH value and HPMC amount was also proposed and validated. The process was considered to happen in two stages: initially, the release medium penetrates the capsule and solubilizes the model compound; then, the model compound is released into the surrounding environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.